Details

Comprehensive molecular characterization of craniopharyngiomas using whole transcriptome and spatial transcriptomics approaches
ID Kert, Špela (Author), ID Matjašič, Alenka (Author), ID Pižem, Jože (Author), ID Mlakar, Jernej (Author), ID Bošnjak, Matic (Author), ID Jerala, Miha (Author), ID Kotnik, Primož (Author), ID Faganel Kotnik, Barbara (Author), ID Kitanovski, Lidija (Author), ID Zupan, Andrej (Author)

.pdfPDF - Presentation file, Download (2,18 MB)
MD5: 1FB57E981DF59B6F3761B7A1F5A8A18E
URLURL - Source URL, Visit https://link.springer.com/article/10.1007/s10014-025-00509-z This link opens in a new window

Abstract
Craniopharyngiomas (CPs) are rare benign brain tumors that are classified as WHO grade I, with two subtypes: adamantinomatous craniopharyngioma (ACP) and papillary craniopharyngioma (PCP). ACP is caused by somatic mutations in exon 3 of the CTNNB1 gene activating the Wnt signaling pathway. PCP is associated with somatic BRAF p.V600E mutations activating the MAPK signaling pathway. Understanding their molecular differences is crucial for diagnosis and treatment. This study aimed to analyze common somatic alterations in ACP and PCP using bulk transcriptome sequencing and in situ spatial transcriptomics. RNA sequencing and high-resolution spatial profiling were used to detect mutations and examine gene expression differences among ACP, PCP, and healthy pituitary tissue. Whole transcriptome sequencing was performed on 24 tumor samples, with healthy pituitary data from the GTEx portal. Bioinformatics analysis utilized the CTAT mutation pipeline, with Sanger sequencing for validation. Results confirmed BRAF p.V600E mutations in all PCP samples and CTNNB1 mutations in all ACP samples. Differential gene expression analysis highlighted distinct molecular profiles and reinforced the involvement of Wnt and MAPK signaling. Spatial profiling identified 41 differentially expressed genes between ACP and PCP. This study provides critical insights into CP biology, supporting improved diagnostics and potential therapeutic strategies.

Language:English
Keywords:craniopharyngioma, differential gene expression, in situ spatial profiling, somatic mutation detection, transcriptional analysis
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2025
Number of pages:Str. 130–142
Numbering:Vol. 42, iss. 4
PID:20.500.12556/RUL-178846 This link opens in a new window
UDC:61
ISSN on article:1433-7398
DOI:10.1007/s10014-025-00509-z This link opens in a new window
COBISS.SI-ID:243867907 This link opens in a new window
Publication date in RUL:30.01.2026
Views:278
Downloads:195
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Brain tumor pathology
Shortened title:Brain tumor pathol.
Publisher:Springer Nature, The Japan Society of Brain Tumor Pathology
ISSN:1433-7398
COBISS.SI-ID:514824217 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:kraniofaringiom, diferencialna genska ekspresija, prostorsko profiliranje in situ, odkrivanje somatskih mutacij, transkripcijska analiza

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P3-0054
Name:Patologija in molekularna genetika

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back